Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Eisai Co. Ltd.
DescriptionHumanized IgG mAb against CD248 endosialin (TEM1)
Molecular Target CD248 endosialin (TEM1)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today